1.Date of the board of directors resolution:2022/03/09
2.General shareholders' meeting date:2022/05/26
3.General shareholders' meeting location:
Building A, 2F., No. 19-10, Sanchong Rd., Nangang Dist., Taipei City, Taiwan
(International Convention Center of Nangang Software Park)
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):Physical shareholders meeting
5.Cause for convening the meeting I.Reported matters:
(1)Year 2021 Business Report
(2)Audit Committee's Review Report on the year 2021 Financial Statements
(3)Report on Employee and Directors Remuneration in year 2021
6.Cause for convening the meeting II.Acknowledged matters:
(1)Year 2021 Business Report and Financial Statements
(2)Year 2021 Profit Distribution
7.Cause for convening the meeting III.Matters for Discussion:
(1)The Amendment of "Articles of Incorporation"
(2)The Amendment of "Procedures for Acquisition or Disposal of Assets"
8.Cause for convening the meeting IV.Election matters:None
9.Cause for convening the meeting V.Other Proposals:None
10.Cause for convening the meeting VI.Extemporary Motions:None
11.Book closure starting date:2022/03/28
12.Book closure ending date:2022/05/26
13.Any other matters that need to be specified:
A Shareholder holding 1% or more of the total number of issued shares may
submit a written proposal for discussion at a regular shareholders meeting.
To facilitate the process of the board of directors, please register the
documents to the company with the contact information and mark
"Proposal for discussion at a regular shareholders meeting" on the envelope
from 2022/03/21 to 2022/03/31 5:00p.m.. Recipient: Department of Finance,
3F., No.3-1, Park St., Nangang Dist., Taipei City, Taiwan.
Telephone: +886-2-2652-5999. Anything not covered by the aforementioned
statement shall be govern by Article 172-1 of the Company Act.
Attachments
Original Link
Original Document
Permalink
Disclaimer
TTY Biopharm Co. Ltd. published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 13:41:03 UTC.
TTY Biopharm Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of pharmaceutical preparations. The Company mainly operates through six business segments including Cancer Drug segment, Healthcare segment, Anti-Infective Drug segment, Domestic Cardiovascular and Gastrointestinal Drug segment, Mainland Medical Drug segment and the Other segment. The main products include oncology medicines, anti-infective medicines and health care medicines. Oncology medicines are mainly anti-cancer and auxiliary drugs. Anti-infective medicines are mainly back-line antimicrobial agents and influenza vaccines. Medical and health care medicines are mainly gastrointestinal health care, bone health care, metabolic health care, infection treatment drugs. The Company distributes its products in domestic and overseas markets.
TTY BIOPHARM COMPANY LIMITED 
